TMCnet News
Research and Markets: Latin America OTC Pharmaceuticals Market 2014-2018 With Bayer HealthCare AG., EMS S.A., Hypermarcas S.A., and Novartis AG DominatingDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/zjf2h4/otc) has announced the addition of the "OTC Pharmaceuticals Market in Latin America 2014-2018" report to their offering. The OTC Pharmaceuticals Market in Latin America market to grow at a CAGR of 14% to 2018 One of the major drivers is the increasing switch from prescription to OTC drugs, which increases the number of OTC drugs available. The development and manufacture of drugs is a complex and time-consuming process, and it requires huge financial investments. As many vendors are facing the problem of declining venture capital investments, they are increasingly following the strategy of outsourcing. Certain vendors outsource different parts of the R&D process (such as product characterization testing and txicology testing) to contract research organizations. Similarly, certain vendors are outsourcing part of their manufacturing process, or even the entire manufacturing process, to various organizations. Thus, outsourcing is one of the main trends in this market at present. Further, the report states that one of the major challenges in the market is the stringent regulations posed by regulatory bodies such as Agência Nacional de Vigilância Sanitária, Brazil. Product recalls negatively affect a company's image, resulting in customers opting for other products available in the market, which leads to a fall in sales. Key vendors dominating this space include:
Other vendors mentioned in the report are:
Key Topics Covered:
For more information visit http://www.researchandmarkets.com/research/zjf2h4/otc |
